Archive: 29/11/2018
Truxima approved as first biosimilar to non-Hodgkin's lymphoma drug
(HealthDay)—Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin's lymphoma drug Rituxan, the agency said Wednesday.
Nov 29, 2018